Gene drive debate must include voices from Africa, elsewhere
By Richard Nchabi Kamwi,
STAT
| 06. 15. 2016
As the spread of mosquito-borne diseases has captured headlines in recent months, so too has a novel approach to mosquito control that might one day stop them: gene drive. Although it is in early development, this promising genetic technique could help end the transmission of many deadly pathogens, including malaria.
Gene drives let modifications made to a single organism spread rapidly through the entire population by making sure that targeted genes are passed on to nearly all its offspring. In theory, it would be possible to use gene drives to create mosquitoes that produce sterile offspring, vastly reducing the number that can transmit malaria or other viruses.
...
While vitally important, these conversations have been missing something invaluable: the perspectives of representatives from malaria-affected countries, largely in South and Central America, Africa, and southern Asia.
Continue reading on STAT
Image via Wikimedia
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...